CN104107388B - 一种提高免疫力抗肿瘤的复方中药组合物及其制备方法和用途 - Google Patents
一种提高免疫力抗肿瘤的复方中药组合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN104107388B CN104107388B CN201310133917.4A CN201310133917A CN104107388B CN 104107388 B CN104107388 B CN 104107388B CN 201310133917 A CN201310133917 A CN 201310133917A CN 104107388 B CN104107388 B CN 104107388B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- tumor
- medicine composition
- mouse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 150000001875 compounds Chemical class 0.000 title claims abstract description 33
- 230000036039 immunity Effects 0.000 title claims abstract description 15
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 239000002131 composite material Substances 0.000 claims abstract description 19
- 235000005340 Asparagus officinalis Nutrition 0.000 claims abstract description 15
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 15
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 15
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 13
- 244000003416 Asparagus officinalis Species 0.000 claims abstract 3
- 235000014375 Curcuma Nutrition 0.000 claims abstract 3
- 244000164480 Curcuma aromatica Species 0.000 claims abstract 3
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract 3
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract 3
- 235000019509 white turmeric Nutrition 0.000 claims abstract 3
- 238000001914 filtration Methods 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 19
- 238000000605 extraction Methods 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 241000220324 Pyrus Species 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 235000021017 pears Nutrition 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 58
- 206010028980 Neoplasm Diseases 0.000 abstract description 49
- 241000699670 Mus sp. Species 0.000 abstract description 22
- 230000002401 inhibitory effect Effects 0.000 abstract description 17
- 208000033065 inborn errors of immunity Diseases 0.000 abstract description 12
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract description 12
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 10
- 201000005202 lung cancer Diseases 0.000 abstract description 10
- 208000020816 lung neoplasm Diseases 0.000 abstract description 10
- 230000036737 immune function Effects 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 5
- 230000001413 cellular effect Effects 0.000 abstract description 3
- 230000001681 protective effect Effects 0.000 abstract description 3
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 2
- 238000002512 chemotherapy Methods 0.000 abstract 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 30
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 26
- 229910000831 Steel Inorganic materials 0.000 description 22
- 239000010959 steel Substances 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 20
- 238000011081 inoculation Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 210000004881 tumor cell Anatomy 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 16
- 230000037396 body weight Effects 0.000 description 15
- 239000006285 cell suspension Substances 0.000 description 14
- 230000005764 inhibitory process Effects 0.000 description 13
- 230000004614 tumor growth Effects 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 241000234427 Asparagus Species 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 229910052697 platinum Inorganic materials 0.000 description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000001291 vacuum drying Methods 0.000 description 10
- 229960004397 cyclophosphamide Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 240000002853 Nelumbo nucifera Species 0.000 description 8
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 8
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 8
- 206010003445 Ascites Diseases 0.000 description 7
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 206010070834 Sensitisation Diseases 0.000 description 6
- 239000003610 charcoal Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 210000001541 thymus gland Anatomy 0.000 description 6
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 102100037850 Interferon gamma Human genes 0.000 description 4
- 108010074328 Interferon-gamma Proteins 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 230000003111 delayed effect Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 238000010172 mouse model Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000002992 thymic effect Effects 0.000 description 4
- 206010014025 Ear swelling Diseases 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000009923 sugaring Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241001065361 Gynostemma Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000005907 cancer growth Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002001 anti-metastasis Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 201000003373 familial cold autoinflammatory syndrome 3 Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310133917.4A CN104107388B (zh) | 2013-04-17 | 2013-04-17 | 一种提高免疫力抗肿瘤的复方中药组合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310133917.4A CN104107388B (zh) | 2013-04-17 | 2013-04-17 | 一种提高免疫力抗肿瘤的复方中药组合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104107388A CN104107388A (zh) | 2014-10-22 |
CN104107388B true CN104107388B (zh) | 2017-09-12 |
Family
ID=51704507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310133917.4A Active CN104107388B (zh) | 2013-04-17 | 2013-04-17 | 一种提高免疫力抗肿瘤的复方中药组合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104107388B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104324336A (zh) * | 2014-11-27 | 2015-02-04 | 蒙毅嘉 | 一种防治食道癌和肝癌的中药组合物 |
US10953059B2 (en) | 2015-06-03 | 2021-03-23 | Chang Gung Medical Foundation Keelung Chang Gung Memorial Hospital | Methods and compositions for treating non-small cell lung cancer |
CN108079185A (zh) * | 2017-12-12 | 2018-05-29 | 广东广发制药有限公司 | 一种黄芪绞股蓝干膏粉、抗骨质疏松的中药制剂及制法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1403147A (zh) * | 2002-10-24 | 2003-03-19 | 河北以岭医药研究院有限公司 | 一种提高机体免疫功能的药物组合物及制备方法 |
CN1582995A (zh) * | 2004-06-15 | 2005-02-23 | 河北以岭医药研究院有限公司 | 一种养正消积药物组合物制剂及制备方法 |
-
2013
- 2013-04-17 CN CN201310133917.4A patent/CN104107388B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1403147A (zh) * | 2002-10-24 | 2003-03-19 | 河北以岭医药研究院有限公司 | 一种提高机体免疫功能的药物组合物及制备方法 |
CN1582995A (zh) * | 2004-06-15 | 2005-02-23 | 河北以岭医药研究院有限公司 | 一种养正消积药物组合物制剂及制备方法 |
Non-Patent Citations (1)
Title |
---|
莪术三棱白花蛇舌草对肿瘤细胞抑制作用的研究;李士怡等;《实用中医内科杂志》;20060630;第20卷(第3期);246-247 * |
Also Published As
Publication number | Publication date |
---|---|
CN104107388A (zh) | 2014-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048959B (zh) | 可双向调节人体机能的铁皮石斛复方制剂及其制备方法 | |
CN104873624B (zh) | 一种用于痛风性关节炎的药物组合物 | |
CN106668321A (zh) | 一种人参枸杞子组合物的制备方法及其产品和应用 | |
CN105079046A (zh) | 一种全灵芝抗肿瘤软胶囊及其制备方法 | |
CN105360824A (zh) | 一种虫草饮料及其制备方法 | |
CN104107388B (zh) | 一种提高免疫力抗肿瘤的复方中药组合物及其制备方法和用途 | |
CN105724642A (zh) | 一种抗氧化抗衰老的黑茶组合物及制备方法 | |
CN101524394B (zh) | 雀嘴茶制剂及其应用 | |
CN102600368A (zh) | 一种药物组合物及其制备方法和用途 | |
CN100381164C (zh) | 一种治疗化疗、放疗、放射病的药物 | |
CN105943617A (zh) | 全麻素在制备抗肝炎药物中的应用 | |
CN105770408A (zh) | 一种灵芝黄精胶囊及其制备方法 | |
CN109602759A (zh) | 罗汉松实多糖的用途 | |
CN105617021A (zh) | 一种以铁皮石斛和牛大力为原料的药物或保健品 | |
CN104784670A (zh) | 一种治疗心肌炎的药物组合物及其制备方法 | |
CN104127757A (zh) | 具有扶正养阴作用的中药组合物及其制备方法和应用 | |
CN101168008B (zh) | 一种具有抑制肿瘤作用的药物组合物及其制备方法和用途 | |
CN101011543B (zh) | 一种新的抗肿瘤药物组合物 | |
CN103784492B (zh) | 具有抗肿瘤作用的铜锤玉带草提取物及其应用 | |
CN107412462A (zh) | 一种黄龙咳喘胶囊的制备方法 | |
CN102178222B (zh) | 一种食用组合物及其制备方法与应用 | |
CN106074710A (zh) | 一种治疗癫痫的药物 | |
CN106075338A (zh) | 保健中药组合物及其制备方法和应用 | |
CN101559166A (zh) | 一种麦冬提取物及其制备方法与降糖应用 | |
CN104840747B (zh) | 具有抗甲状腺癌活性的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee after: Tianjin Institute of Pharmaceutical Research Co.,Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231018 Address after: 4th Floor, Building B1, No. 306 Huiren Road, Binhai Science and Technology Park, Binhai New Area, Tianjin, 300301 Patentee after: Heguang Traditional Chinese Medicine Technology (Tianjin) Co.,Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |